It is becoming clearer that genetic mutations that are usually tobacco-induced, and in particular the p53 mutation, can negatively influence the prognosis of HPV-positive OPSCC and make, in general, head and neck squamous cell carcinomas less responsive to therapy, compromising the outcomes of such patients. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.